Gefitinib hydrochloride,
184475-55-6,
gefitinib hcl,
Gefitinib (hydrochloride),
ZD-1839 hydrochloride,
Gefitinib hydrochloride salt,
4-(3-chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride,
4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazolinehydrochloride,
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-, monohydrochloride,
iressa hydrochloride,
C22H24ClFN4O3.HCl,
SCHEMBL11776,
DTXSID10597850,
QUINXWLATMJDQF-UHFFFAOYSA-N,
BCP05217,
CG0032,
HY-50895A,
MFCD00952718,
AKOS015900843,
API0010344,
BCP9000719,
CS-1587,
AS-19174,
X5007,
Z-3215,
475G556,
J-011820,
I14-16346,
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-,monohydrochloride,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,hydrochloride,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine hydrochloride,
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine--hydrogen chloride (1/1),
ZD 1839,
A3433,
A15093,